What Atreca, Inc.'s executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 0 | 0 |
| Total trades | 0 | 0 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 0 |
| Disposed | 0 | 0 |
| Net activity | +0 | +0 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Orwin John A | PRESIDENT & CEO | Apr 11 | Open-market buy · P | +1 | $0.01 | +$0.01 | 1 |
| Serafini Tito | Director | Apr 01 | Sale for tax withholding · S | −20,788 | $0.07 | −$1.46K | 43,636 |
| Baker Bros. Advisors Lp | Insider | Oct 19 | Open-market sale · S | −251,902 | $0.40 | −$101K | 2,971,128 |
| Baker Bros. Advisors Lp | Insider | Oct 19 | Open-market sale · S | −22,837 | $0.40 | −$9.19K | 286,893 |
| Courtney Phillips | GENERAL COUNSEL & SECRETARY | Sep 01 | Sale for tax withholding · S | −7,061 | $0.37 | −$2.65K | 50,431 |
| Orwin John A | PRESIDENT & CEO | Sep 01 | Sale for tax withholding · S | −22,951 | $0.37 | −$8.6K | 77,541 |
| Serafini Tito | Director | Sep 01 | Sale for tax withholding · S | −8,393 | $0.37 | −$3.14K | 64,424 |
| Courtney Phillips | General Counsel & Secretary | Aug 02 | Sale for tax withholding · S | −4,076 | $0.95 | −$3.88K | 57,492 |
| Gould Stephen E | Chief Scientific Officer | Aug 02 | Sale for tax withholding · S | −4,076 | $0.95 | −$3.88K | 28,424 |
| Cross Herb | Chief Financial Officer | Aug 02 | Sale for tax withholding · S | −5,487 | $0.95 | −$5.22K | 72,817 |
| Serafini Tito | Chief Strategy Officer | Aug 02 | Sale for tax withholding · S | −5,487 | $0.95 | −$5.22K | 72,817 |
| Courtney Phillips | General Counsel & Secretary | Feb 09 | Grant / award · A | +32,500 | — | — | 61,568 |
| Gould Stephen E | Chief Scientific Officer | Feb 09 | Grant / award · A | +32,500 | — | — | 32,500 |
| Cross Herb | Chief Financial Officer | Feb 09 | Grant / award · A | +43,750 | — | — | 78,304 |
| Serafini Tito | Chief Strategy Officer | Feb 09 | Grant / award · A | −43,750 | — | — | 78,304 |
| Courtney Phillips | General Counsel & Secretary | Sep 02 | Sale for tax withholding · S | −6,432 | $1.78 | −$11.4K | 29,068 |
| Orwin John A | President & CEO | Sep 02 | Sale for tax withholding · S | −20,908 | $1.78 | −$37.1K | 100,492 |
| Serafini Tito | Chief Strategy Officer | Sep 02 | Sale for tax withholding · S | −7,646 | $1.78 | −$13.6K | 34,554 |
| Cross Herb | Chief Financial Officer | Sep 02 | Sale for tax withholding · S | −7,646 | $1.78 | −$13.6K | 34,554 |
| Serafini Tito | Chief Strategy Officer | Jun 28 | Disclosed 10b5-1 sale · S | −15,000 | $2.02 | −$30.3K | 228,875 |
Loading...
